Rubella virus infection has long been associated with musculoskeletal pain syndromes ranging in severity from mild muscle and joint aching of a few days duration to the development of frank arthritis with long-term residual joint disease. 1-7 Symptoms usually begin within one week of the appearance of rash in wild rubella infection or in the two-to four-week period after rubella immunisation.
The incidence is rare in infants and young children but increases in frequency in postpubertal age groups,' 2 when it is the principal adverse reaction associated with adult rubella immunisation. (Fig. 1) . By six months postimmunisation four individuals were having recurrent episodes of joint symptoms (one with arthritis and three with arthralgias). By 18 to 24 months postimmunisation two individuals (4-5%) were continuing to experience recurrent episodes of arthritis or arthralgia. Recurrent joint symptoms were noted at a higher frequency in those presenting initially with more severe disease, i.e., objective arthritis, than in those presenting simply with arthralgia (Fig. 2) .
Rubella Vaccine Group
Among members of the wild rubella group Perhaps the most striking feature of the present study is the observation that a significant proportion of both vaccine and witd rubella infection groups developed prolonged or recurrent joint manifestations lasting over 18 months postinfection. Previous studies have placed particular emphasis on acute transient joint manifestations,' 2 9t2 14118 whereas fewer studies have examined the duration of symptoms for prolonged periods postinfection.35 19 The present study documents continuing active joint manifestations of 18 months or longer duration in 4-5% of the vaccine study group and 30-4% of females and 8-7% of males in the wild rubella study group. In both vaccine and wild rubella infection groups continuing joint symptoms occurred far more frequently in individuals presenting initially with arthritis than in those presenting with arthralgias.
